300685 艾德生物
按盤價 
18.630 +0.130 (+0.703%)
18.630 +0.130 (+0.703%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 8.299 | 16.327 | 18.416 | 19.219 | 17.760 |
| 總資產報酬率 ROA (%) | 7.334 | 14.584 | 16.636 | 17.035 | 15.415 |
| 投入資產回報率 ROIC (%) | 8.016 | 15.739 | 17.948 | 19.024 | 15.740 | 邊際利潤分析 |
| 銷售毛利率 (%) | 85.153 | 83.968 | 82.449 | 84.376 | 86.965 |
| 營業利潤率 (%) | 29.496 | 28.869 | 34.157 | 27.615 | 27.752 |
| 息稅前利潤/營業總收入 (%) | 27.285 | 25.779 | 30.404 | 28.257 | 28.703 |
| 淨利潤/營業總收入 (%) | 26.492 | 25.058 | 31.382 | 26.065 | 24.757 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 100.665 | 101.688 | 62.944 | 94.483 | 88.045 |
| 價值變動淨收益/利潤總額(%) | 3.243 | -0.678 | 0.691 | 3.299 | 0.611 |
| 營業外收支淨額/利潤總額(%) | -1.102 | -2.167 | -0.552 | -0.500 | -0.716 | 償債能力分析 |
| 流動比率 (X) | 7.981 | 9.288 | 13.974 | 8.845 | 6.737 |
| 速動比率 (X) | 7.826 | 9.123 | 13.617 | 8.607 | 6.594 |
| 資產負債率 (%) | 11.294 | 11.968 | 9.158 | 9.886 | 12.716 |
| 帶息債務/全部投入資本 (%) | 2.675 | 2.740 | 2.956 | 0.072 | -- |
| 股東權益/帶息債務 (%) | 3,611.902 | 3,524.047 | 3,255.050 | 137,476.032 | -21,966.057 |
| 股東權益/負債合計 (%) | 785.398 | 735.583 | 991.900 | 908.205 | 686.406 |
| 利息保障倍數 (X) | -14.439 | -10.407 | -8.527 | 36.239 | 25.003 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 179.489 | 168.117 | 188.285 | 146.288 | 0.000 |
| 存貨周轉天數 (天) | 69.026 | 66.302 | 79.288 | 67.469 | 0.000 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 15/08/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
